Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’
The Guardianقراءة 1 د1 قراءة
Cancer undetectable for one in 12 patients in daraxonrasib trial, while nearly all participants’ tumours stopped growing
A year after starting treatment, 76.6% of patients were alive; usually 40-45 % of patients given chemotherapy alone survive a year. Photograph: Jeff Moore/PAA year after starting treatment, 76.6% of patients were alive; usually 40-45 % of patients given chemotherapy alone survive a year. Photograph: Jeff Moore/PAPill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’
Cancer undetectable for one in 12 patients in daraxonrasib trial, while nearly all participants’ tumours stopped growing